ESC Congress 2026 Abstract·Oct 26The Apolipoprotein A2/Apolipoprotein C3 ratio predicts future cardiovascular events after percutaneous coronary intervention in patients receiving LDL-cholesterol-lowering therapyCohort study of 649 peopleChronic coronary syndromePaper